CONTRASTING LATERITIC NICKEL ORE CHARACTERISTICS IN EASTERN INDONESIA: THE URGENCY OF SHIFTING FROM RKEF TO HPAL
INTAN Jurnal Penelitian Tambang · 30.05.2026 · 9 (1) · 24-37
DOI: 10.56139/intan.v9i1.371 ↗Kurz gefasst
Fachartikel in der Zeitschrift INTAN Jurnal Penelitian Tambang, online erschienen am 30.05.2026. Verfasst von Renny Cahyaningtyas und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
While Indonesia holds a strategic position in the global electric vehicle (EV) supply chain, with 19.16 billion tons of nickel resources, this dominance is threatened by a critical mismatch between geological realities and the downstream industrial structure. This paper analyzes the disparity within the national ore balance and assesses the urgency of transitioning processing technologies to secure long-term sustainability. Using an economic geology approach, we conducted a geometallurgical characterization of regional deposits (Sulawesi, Maluku, Papua) and a mass balance analysis based on the 2025 Mineral Resource and Reserve Balance. Findings indicate that 58% of national resources are limonite (Ni
Zitieren
APA
Cahyaningtyas, R., Nurkhamim, & Winarno, E. (2026). CONTRASTING LATERITIC NICKEL ORE CHARACTERISTICS IN EASTERN INDONESIA: THE URGENCY OF SHIFTING FROM RKEF TO HPAL. INTAN Jurnal Penelitian Tambang, 9(1), 24-37. https://doi.org/10.56139/intan.v9i1.371
Vancouver
Cahyaningtyas R, Nurkhamim, Winarno E. CONTRASTING LATERITIC NICKEL ORE CHARACTERISTICS IN EASTERN INDONESIA: THE URGENCY OF SHIFTING FROM RKEF TO HPAL. INTAN Jurnal Penelitian Tambang. 2026;9(1):24-37. doi:10.56139/intan.v9i1.371
BibTeX
@article{Cahyaningtyas2026,
author = {Cahyaningtyas, Renny and Nurkhamim and Winarno, Eddy},
title = {CONTRASTING LATERITIC NICKEL ORE CHARACTERISTICS IN EASTERN INDONESIA: THE URGENCY OF SHIFTING FROM RKEF TO HPAL},
journal = {INTAN Jurnal Penelitian Tambang},
year = {2026},
volume = {9},
number = {1},
pages = {24--37},
doi = {10.56139/intan.v9i1.371}
}
EUVIMED